Clinical Trial Update: Relevance of Peripheral Cells in the Pathophysiology of Chronic Myelomonocytic Leukemia (CMML)

View source ↗

Summary

This document provides an update on the relevance of peripheral cells in the pathophysiology of Chronic Myelomonocytic Leukemia (CMML).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelomonocytic Leukemia

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Chronic Myelomonocytic Leukemia | Status: UNKNOWN